Cutler Group LP Tyme Technologies, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 14, 2022	SELL	$0.28 - $0.68 $476 - $1,156	-1,700 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$0.6 - $1.04 $11,700 - $20,280	-19,500 Reduced 91.98%	1,700 $1,000
Q3 2021 Oct 26, 2021	BUY	$0.99 - $1.38 $16,731 - $23,322	16,900 Added 393.02%	21,200 $21,000
Q2 2021 Jul 19, 2021	SELL	$1.14 - $1.87 $16,872 - $27,676	-14,800 Reduced 77.49%	4,300 $5,000
Q1 2021 Apr 26, 2021	BUY	$1.34 - $3.53 $24,120 - $63,540	18,000 Added 1636.36%	19,100 $33,000
Q1 2020 May 07, 2020	BUY	$0.9 - $1.95 $450 - $975	500 Added 83.33%	1,100 $1,000
Q3 2019 Oct 28, 2019	BUY	$0.97 - $1.77 $582 - $1,062	600 New	600 $0

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.